Investors have seen a range of outcomes for after-hours stock carriers in recent weeks. Micron Technology’s shares dropped 6% following the release of its quarterly results and guidance, despite beating analyst expectations for the third and fourth quarters. Despite reporting positive earnings, investors were disappointed with the company’s revenue growth and gross margins.
Recursion Pharmaceuticals also experienced a decline in stock prices, falling 8% after announcing a planned public offering of $200 million in Class A common stock. The company is seeking to raise capital to fund its ongoing research and development efforts and expand its operations globally.
Levy’s shares fell 12% after its full-year earnings per share (EPS) guidance fell short of analyst expectations. The company has faced challenges in recent years due to rising costs and declining sales, which have led to concerns about its future profitability.
AeroVision’s shares fell 7% despite reporting better-than-expected earnings for the fourth quarter. However, the company’s guidance for the next quarter only met analysts’ expectations, leading investors to question the sustainability of its growth prospects.
CASI Pharma saw a significant increase in stock prices, rising by 75%, after receiving a letter from the company’s president and CEO proposing to take over its operations in China. The acquisition would allow CASI Pharma to expand into one of the world’s largest pharmaceutical markets and gain access to new technologies and resources.
Shares of Citigroup edged up slightly by 0.25%, while Wells Fargo and US Bancorp were down after hours following news that major US banks are well prepared to weather a severe recession but may fall short of minimum capital requirements if interest rates continue to rise rapidly. HB Fuller saw its shares rise by 5% after reporting positive second-quarter results and providing strong guidance for future growth opportunities.